A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver"

Cell. 2020 Jun 11;181(6):1406-1409.e2. doi: 10.1016/j.cell.2020.04.029.

¹ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: [email protected].
² Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
³ Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford OX3 7DQ, UK.
⁴ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: [email protected].

No abstract available

Publication types